Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

• Status: Completed
• Trial end date: 2006-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Female

• Stress urinary incontinence

Exclusion Criteria:

• Bladder outflow obstruction

• Neurological disease